{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:13:53Z","timestamp":1784031233236,"version":"3.55.0"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,2,21]]},"abstract":"<jats:p>\n            Antistaphylococcal penicillins such as nafcillin and oxacillin are among the first choices of treatment for severe invasive methicillin-susceptible\n            <jats:named-content content-type=\"genus-species\">Staphylococcus aureus<\/jats:named-content>\n            (MSSA) infections, although there has been limited safety evaluations between individual agents.\n          <\/jats:p>","DOI":"10.1128\/aac.01818-19","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T13:00:06Z","timestamp":1576501206000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4542-6203","authenticated-orcid":false,"given":"Tristan T.","family":"Timbrook","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Utah, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"McKay","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Utah, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse D.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Spivak","sequence":"additional","affiliation":[{"name":"Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA"},{"name":"Department of Internal Medicine, Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/599376"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis966"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000296"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ482"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02800-14"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01816-17"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2018.02.004"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.11.013"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.03.010"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03122-15"},{"key":"e_1_3_3_12_2","volume-title":"IDWeek 2018, 3 to 7 October 2018","author":"Timbrook TT","year":"2018","unstructured":"Timbrook TT, Sutton J, Spivak E. 2018. Disproportionality analysis of safety with nafcillin and oxacillin with the FDA Adverse Event Reporting System (FAERS) [abstr 1407]. IDWeek 2018, 3 to 7 October 2018, San Francisco, CA."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.302"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/338047"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/2047-2501-2-3"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix287"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz270"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00317-09"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.07.001"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy123"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu213"},{"key":"e_1_3_3_23_2","volume-title":"Oxacillin drug monograph, 11\/9\/2019 ed","author":"Lexi-Comp","year":"2019","unstructured":"Lexi-Comp. 2019. Oxacillin drug monograph, 11\/9\/2019 ed. Wolters Kluwer Clinical Drug Information, Inc., Hudson, OH."},{"key":"e_1_3_3_24_2","volume-title":"Nafcillin drug monograph, 11\/08\/2019 ed","author":"Lexi-Comp","year":"2019","unstructured":"Lexi-Comp. 2019. Nafcillin drug monograph, 11\/08\/2019 ed. Wolters Kluwer Clinical Drug Information, Inc., Hudson, OH."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01818-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01818-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:46:25Z","timestamp":1645479985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01818-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2,21]]}},"alternative-id":["10.1128\/AAC.01818-19"],"URL":"https:\/\/doi.org\/10.1128\/aac.01818-19","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"assertion":[{"value":"2019-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01818-19"}}